A Study to Evaluate the Effect of Repeat Oral Dosing of GSK2118436 on Cardiac Repolarization in Subjects With V600 BRAF Mutation-Positive Tumors
Clinical trial NCT01738451 · COMPLETED
Trial details
- NCT number
- NCT01738451
- Sponsor
- GlaxoSmithKline
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2013-01-22
- Primary completion
- 2014-11-28
- Enrollment
- 50
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.